Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Nearly 75% of Americans are classified as overweight or obese. Addressing our nation's health crisis requires much more than ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Wegovy, a semaglutide injection, aids in weight loss by suppressing appetite and boosting metabolism, now available in South ...

Pharmacy benefit managers started popping up in the late 1960s as providers of claims processing and administrative services ...

Ozempic and Wegovy, used for diabetes and weight loss, show a link to NAION, a rare eye disorder causing blindness. A study ...

Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have taken drugs like Ozempic, Wegovy and Mounjaro. Demand for the drugs has ...

Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy Wednesday’ had already become one of the biggest weight-loss trends to sweep the ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...